BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2021
View Archived Issues
A virus-specific nanobody lowers latent viral loads in HCMV-infected cells
Read More
Clinical hold extended for ORTHO-R phase I/II study
Read More
Genexine describes anti-TAA, anti-PD-L1, TNFRSF9 ligand fusion proteins
Read More
Sumitomo Dainippon Pharma Oncology patents serine/threonine kinase Nek2 inhibitors
Read More
New SREBP inhibitors identified at Capulus Therapeutics
Read More
Shanghai Bowei Biological Technology, collaborators divulge polynucleotides for expressing HPV 51L1
Read More
KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity
Read More
APP gene mutation causes autosomal dominant Alzheimer's disease
Read More
Salicylanilide compounds show promise for treating COVID-19
Read More
Improved serum metabolic profile and symptoms in patients with ALS treated with ILB
Read More
AAV gene therapy targeting CaMKII protects retinal ganglion cells, preserves vision
Read More
ACMT reports on patients becoming ill from use of ivermectin for COVID-19
Read More
Bavarian Nordic studies ABNCoV2 as COVID-19 booster vaccine in phase II
Read More
FDA clears IND for clinical trials of siroquine for newly diagnosed GBM
Read More
Phase I data reported for GDC-3280 in healthy subjects
Read More
Cytokine-induced JAK/STAT signaling plays role in cachexia
Read More
KalVista gains clinical trial approvals for phase II trial of KVD-824 for HAE
Read More